NDC 68788-9809-01 - LISINOPRIL AND HYDROCHLOROTHIAZIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68788-9809
- Requested NDC
- 68788-9809-01
- Package NDCs from labels
- 68788-9809-3, 68788-9809-6, 68788-9809-9, 68788-9809-1, 68788-9809-01
- Manufacturer
- Preferred Pharmaceuticals, Inc.
- Effective date
- 2026-05-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS USP | Preferred Pharmaceuticals, Inc. | 2026-05-22 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68788-9809-1 | LISINOPRIL AND HYDROCHLOROTHIAZIDE | 100 in 1 BOTTLE | TABLET | 100 | 13 | |
| 68788-9809-3 | LISINOPRIL AND HYDROCHLOROTHIAZIDE | 30 in 1 BOTTLE | TABLET | 30 | 13 | |
| 68788-9809-6 | LISINOPRIL AND HYDROCHLOROTHIAZIDE | 60 in 1 BOTTLE | TABLET | 60 | 13 | |
| 68788-9809-9 | LISINOPRIL AND HYDROCHLOROTHIAZIDE | 90 in 1 BOTTLE | TABLET | 90 | 13 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68788-9809 | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [PREFERRED PHARMACEUTICALS, INC.] | 11 | Current NDC, Legacy NDC, 4 package rows | 20240621_5aa18b0b-4688-493a-a5ae-cb056ea6c0e3.zip |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ferrum Oxydatum | FERRUM OXYDATUM | Hahnemann Laboratories, INC. | f8b52d3f-3fe2-a850-e053-6394a90a5d9f | 2023-04-06 | 1K09F3G675 | |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Aphena Pharma Solutions - Tennessee, LLC | 69c41abb-75f4-429b-905a-1ce967924aee | 2023-04-04 | Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Proficient Rx LP | 3464be28-5bab-4642-9d9b-8b425822dd07 | 2023-04-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | Exelan Pharmaceuticals, Inc. | c40b15ec-6083-4778-bca8-3e895e5694e1 | 2023-03-28 | Boxed warning, Warnings, Adverse reactions | 197886 197885 197887 E7199S1YWR 0J48LPH2TH |
| Alumina | ALUMINUM OXIDE | Boiron | 84274737-2fed-d542-e053-2a91aa0a1ead | 2023-03-28 | LMI26O6933 | |
| Lisinopril | LISINOPRIL | A-S Medication Solutions | 24f678c8-bb66-481e-b42b-1367cbff3169 | 2023-03-27 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Alumina | ALUMINUM OXIDE | Boiron | 84270ebe-2cd9-7fb5-e053-2a91aa0ab7d5 | 2023-03-27 | LMI26O6933 | |
| Mannitol | MANNITOL | Fresenius Kabi USA, LLC | c395e13d-6ea1-4104-8b37-669cfb982f04 | 2023-03-16 | Warnings, Adverse reactions | 3OWL53L36A |
| Lisinopril | LISINOPRIL | A-S Medication Solutions | 051375d4-7d38-45b3-9ca4-f2cd1f527b1b | 2023-03-13 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Actavis Pharma, Inc. | afdf1170-25a0-496d-b293-36ee0db2cd1e | 2023-03-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| CAPTOPRIL AND HYDROCHLOROTHIAZIDE | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | Rising Pharma Holdings, Inc. | 0ea90fd4-0da6-4ad2-ab83-6cfbe0ae515e | 2023-02-21 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | ef100fa1-dd63-4287-8543-480a82ace168 | 2023-02-06 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | f1ef2a2c-7b8d-4127-8f47-29e430fba70b | 2023-02-06 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 54224596-325d-473e-adb5-1c86857aba34 | 2023-02-04 | Warnings, Adverse reactions | 0J48LPH2TH |
| LISINOPRIL | LISINOPRIL | A-S Medication Solutions | b5683ac4-59dc-4772-8bc6-984c698afbeb | 2023-02-04 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Proficient Rx LP | c1052d38-fd75-40c2-a685-0e889009be0b | 2023-02-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | Proficient Rx LP | 84dba61d-cae2-4f21-9a9e-3088f356f838 | 2023-02-01 | Boxed warning, Warnings, Adverse reactions | 197886 E7199S1YWR 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Proficient Rx LP | c4fe84e3-c291-4220-95c1-a2bd02b1e134 | 2023-02-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Limited | 34703033-14c4-459c-8b8f-2f2e1145aff7 | 2023-01-30 | Warnings, Adverse reactions | 0J48LPH2TH |
| Irbesartan and Hydrochlorothiazide | IRBESARTAN AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Limited | 9492a1cd-c012-4b43-931d-235220065e1e | 2023-01-30 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.